Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT01891981 · TERMINATED
Trial details
- NCT number
- NCT01891981
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-17
- Primary completion
- 2017-04-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.